ArticleGenes & diseases2025

Selectively targeting BCL6 using a small-molecule inhibitor is a potential therapeutic strategy for glioblastoma.

Min Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.